|
8K6E
LnaB-Actin-PRUb ternary complex
Deposited 2023-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–375(375 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;289 K;PEG 8000; Sodium chloride; Sodium HEPES
|
Resolution 2.74 Å
R-free 0.245
|
|
8K6F
LnaB-Actin-PRUb ternary complex
Deposited 2023-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–375(375 aa)
Chain B
1–375(375 aa)
|
Not recorded
|
ATP ADENOSINE-5'-TRIPHOSPHATE × 2
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;289 K;PEG8000, Sodium Choride, Sodium HEPES
|
Resolution 3.41 Å
R-free 0.243
|
|
8K6I
LnaB-Actin-PRUb ternary complex
Deposited 2023-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–375(375 aa)
Chain B
1–375(375 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;289 K;Sodium Chloride, PEG8000, HEPES
|
Resolution 3.19 Å
R-free 0.315
|
|
8K6R
LnaB-Actin-PRUb ternary complex in the presence of AMPPNP
Deposited 2023-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–375(375 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;289 K;Sodium Chloride, Sodium HEPES, PEG8000
|
Resolution 2.76 Å
R-free 0.261
|
|
8K6V
LnaB-Actin-PRUb ternary complex
Deposited 2023-07-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–375(375 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
AR6 [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;289 K;Magnesium acetate, MOPS, PEG8000
|
Resolution 2.60 Å
R-free 0.307
|